| Diabetes mellitus treatment using herbal drugs S Verma, M Gupta, H Popli, G Aggarwal International Journal of Phytomedicine 10 (1), 1-10, 2018 | 117 | 2018 |
| Preclinical development of inhalable D-cycloserine and ethionamide to overcome pharmacokinetic interaction and enhance efficacy against Mycobacterium tuberculosis R Ranjan, A Srivastava, R Bharti, T Roy, S Verma, L Ray, A Misra Antimicrobial Agents and Chemotherapy 63 (6), 10.1128/aac. 00099-19, 2019 | 12 | 2019 |
| Transient transfection of the respiratory epithelium with gamma interferon for host-directed therapy in pulmonary tuberculosis R Bharti, A Srivastava, T Roy, K Verma, DVS Reddy, H Shafi, S Verma, ... Molecular Therapy-Nucleic Acids 22, 1121-1128, 2020 | 8 | 2020 |
| Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis R Bharti, T Roy, S Verma, DVS Reddy, H Shafi, K Verma, SK Raman, ... Tuberculosis 134, 102198, 2022 | 7 | 2022 |
| Local Drug Delivery Based Treatment Approaches for Effective Management of Periodontitis G Aggarwal, S Verma, M Gupta, M Nagpal Current Drug Therapy 14 (2), 135-152, 2019 | 5 | 2019 |
| Inhaled Adjunct therapy with second-line drug candidates for dose reduction in chemotherapeutic regimens for multi-drug-resistant tuberculosis S Verma, NJK Dal, A Srivastava, R Bharti, DV Siva Reddy, HS Sofi, T Roy, ... AAPS PharmSciTech 24 (5), 130, 2023 | 3 | 2023 |
| Preparation and evaluation of low-dose calcitriol dry powder inhalation as host-directed adjunct therapy for tuberculosis DVS Reddy, H Shafi, R Bharti, T Roy, S Verma, SK Raman, K Verma, ... Pharmaceutical Research 39 (10), 2621-2633, 2022 | 3 | 2022 |
| Transcriptional regulation of suppressors of cytokine signaling during infection with Mycobacterium tuberculosis in human THP-1-derived macrophages and in mice T Roy, A Seth, H Shafi, DVS Reddy, SK Raman, J Chakradhar, S Verma, ... Microbes and Infection 26 (3), 105282, 2024 | | 2024 |
| A Quality by Design Approach for Developing SNEDDS Loaded with Vemurafenib for Enhanced Oral Bioavailability C Jvus, N Kothuri, S Singh, S Verma, H Shafi, DVS Reddy, A Kedar, ... AAPS PharmSciTech 25 (1), 14, 2024 | | 2024 |
| Correction: Preparation and Evaluation of Low-Dose Calcitriol Dry Powder Inhalation as Host-Directed Adjunct Therapy for Tuberculosis DVS Reddy, H Shaf, R Bharti, T Roy, S Verma, SK Raman, K Verma, ... Pharmaceutical Research 39 (11), 3039, 2022 | | 2022 |
| Elusive empowerment: characteristics of indirectly elected women chairpersons of district councils in Uttar Pradesh, India P Choudhari, T Roy, K Verma, R Bharti, S Verma Commonwealth Journal of Local Governance, 5-19, 2021 | | 2021 |
Reena BhartiPostdoctoral Researcher, University of California, San FranciscoVerified email at ucsf.edu
